股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 世紀建業(集團)有限公司 呈交日期: 2026年4月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00079 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | 本月底法定/註冊 ...

Financial Performance - Total revenue for the year ended December 31, 2025, was HKD 45,956,000, a decrease of 4.5% from HKD 48,042,000 in 2024[2] - Gross profit for 2025 was HKD 14,739,000, compared to HKD 15,064,000 in 2024, reflecting a decline of 2.2%[2] - The company reported a loss before tax of HKD 15,814,000 for 2025, down from a loss of HKD 32,392,000 in 2024, indicating an improvement of 51.1%[2] - The total comprehensive loss for the year was HKD 15,584,000, compared to HKD 31,821,000 in the previous year, representing a reduction of 51.0%[4] - Basic and diluted loss per share for 2025 was HKD 4.34, improved from HKD 9.53 in 2024[4] - The company's net loss decreased by 51% to approximately HKD 15,583,000, influenced by a reduction in gross profit and an increase in impairment losses on right-of-use assets[33] - Revenue for the year decreased by approximately 4% to HKD 45,956,000, primarily due to declines in hair design revenue, hospitality service income, and securities investment income by 4%, 2%, and 33% respectively[33] Assets and Liabilities - Non-current assets decreased to HKD 298,123,000 in 2025 from HKD 315,685,000 in 2024, a decline of 5.6%[5] - Current assets increased slightly to HKD 65,132,000 in 2025 from HKD 64,146,000 in 2024, an increase of 1.5%[5] - Total liabilities remained stable at HKD 146,266,000 in 2025, compared to HKD 146,103,000 in 2024[6] - The company's equity attributable to owners decreased to HKD 207,147,000 in 2025 from HKD 221,297,000 in 2024, a decrease of 6.4%[6] - The total assets for the group decreased from HKD 379,831,000 in 2024 to HKD 363,255,000 in 2025, a decline of approximately 4.4%[16] - The total liabilities for the group slightly decreased from HKD 159,178,000 in 2024 to HKD 158,186,000 in 2025[16] - The net asset value of the company as of December 31, 2025, was approximately HKD 205,069,000, with a net asset value per share of approximately HKD 0.63[34] - Total assets and total liabilities were approximately HKD 363,255,000 and HKD 158,186,000 respectively[34] - The total equity of the group as of December 31, 2025, was HKD 205,069,000, with fixed liabilities of HKD 12,741,000, floating liabilities of HKD 116,270,000, and interest-free liabilities of HKD 29,175,000, representing 6%, 57%, and 14% of total equity respectively[59] Revenue by Segment - The company recognized revenue from hair design services of HKD 12,041,000 in 2025, down from HKD 12,397,000 in 2024, a decline of 2.9%[10] - The segment profit for the hair design division in 2025 was a loss of HKD 1,029,000, compared to a profit of HKD 12,000 in 2024[13] - The property investment segment reported a revenue of HKD 2,928,000 in 2025, down from HKD 3,174,000 in 2024, representing a decrease of 7.8%[13] - The hotel and hospitality services segment reported a loss of HKD 9,844,000 in 2025, compared to a loss of HKD 3,276,000 in 2024[13] - The hairdressing business segment reported a revenue decline of approximately 4% to HKD 12,412,000, with service revenue down by 3% and product sales decreasing by 21%[40] Impairment and Losses - The group recognized an impairment loss of HKD 11,808,000 for the year 2025, compared to HKD 1,378,000 in 2024[17] - The impairment loss on right-of-use assets increased by HKD 10,960,000 compared to the previous year[33] - The valuation loss of investment properties amounted to HKD 7,400,000, leading to a segment loss of HKD 12,871,000 for the year, with total valuation of investment properties declining to HKD 79,700,000[35] Operational Insights - The group plans to open a new "key-in-hand" salon to attract younger customers with more affordable services, expanding its market presence[44] - The group is committed to enhancing operational efficiency and prudent cost management to drive revenue growth amid competitive pressures in the hotel industry[44] - The group anticipates a challenging operational environment in 2026 due to structural challenges in the hotel industry and changing consumer preferences[65] - The group remains confident in the long-term prospects of its core markets, including Hong Kong and Macau, supported by national development plans[64] Market and Economic Conditions - The Hong Kong retail sales showed a moderate recovery with an annual growth of about 1%, marking the first positive cumulative growth since March 2024[37] - Macau's GDP grew by 4.7%, driven by a strong recovery in tourism and gaming services, although structural challenges remain for overall economic breakthrough[37] - The Hong Kong tourism industry welcomed 49.9 million visitors in 2025, a 12% increase year-on-year, with mainland Chinese visitors growing by 11%[45] - The government is implementing a HKD 1.2 billion initiative to support the tourism industry, which is expected to enhance growth in retail, dining, and hotel sectors[48] - The rise of lifestyle hotels is becoming a key growth driver, reflecting a shift in traveler preferences towards experiential stays rather than just accommodation[48] Investments and Financial Markets - The performance of the group's securities investment portfolio is influenced by global and regional economic conditions, as well as financial market volatility[49] - The group's financial assets measured at fair value amounted to approximately HKD 52,733,000 as of December 31, 2025, compared to HKD 43,000,000 as of December 31, 2024[50] - The group recorded dividend income from securities investments of HKD 1,785,000 during the year[50] - The Hang Seng Index surged by 27.8% in 2025, driven by factors such as inflows from the "Southbound Trading" scheme, optimism regarding AI development, and interest rate cuts[50] - The S&P 500 index increased by 16% to 18% in 2025, marking the third consecutive year of double-digit growth, with AI-related tech stocks contributing over half of the index's returns[51] Employee and Operational Costs - The total employee cost (excluding director remuneration) for the year ended December 31, 2025, was approximately HKD 13,363,000, compared to HKD 13,166,000 in 2024[61] - The group employed approximately 45 staff as of December 31, 2025, consistent with the previous year[61] Corporate Governance - The group did not recommend the payment of a final dividend for the year ended December 31, 2025[62] - The group did not have any significant investments, acquisitions, or disposals during the year ended December 31, 2025[60] - The company's financial statements for the year ending December 31, 2025, have been verified for consistency with the audited financial statements[68] - No shares were repurchased, bought, or sold by the company or its subsidiaries during the year[69] - The company has adopted the standard code of conduct for securities transactions as per the listing rules, and all directors confirmed compliance during the review year[71] - The annual performance announcement and the 2025 annual report will be published on the Hong Kong Stock Exchange's website and the company's website[72]

於本公佈刊發日期，董事會包括七名董事，其中三名爲執行董事，即 曾昭武先生(行政主席)、曾昭婉女士及朱明德女士；以及四名獨立非 執行董事，即許人傑先生、劉沛榮先生、何婷媚女士及吳斌全先生。 CENTURY LEGEND (HOLDINGS) LIMITED 世紀建業（集團）有限公司* (於百慕達註冊成立的有限公司) (股份代號: 00079) 董事會會議通告 世紀建業(集團)有限公司（「本公司」）董事會（「董事會」）宣佈， 董事會會議將於二零二六年三月二十七日下午四時正假香港灣仔告 士打道 151 號資本中心 9 樓 903 室舉行，旨在（其中包括）批准本公 司及其附屬公司截止二零二五年十二月三十一日止全年業績公佈及 考慮建議派發末期股息（如有）。 承董事會命 世紀建業(集團)有限公司 公司秘書 施得安 香港，二零二六年三月十七日 * 僅供識別 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任 何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 CENTURY LEGEND (HOLDINGS) LIMITED 世紀建業（集團）有限公司* (於百慕達註冊成立的有限公司) (股份代號: 00079) 須予披露交易 出售上市證券 於二零二五年十二月十七日及二零二六年三月六日，本公司經其全資附屬公司於市場 上出售總數合 2,700 股 PLTR 股份，平均售價為每股 PLTR 股份約 163.66 美元，出售 所得款項總額 441,880 美元，等值約港幣 3,446,664 元（不包括交易成本）。出售事項 後，本集團持有 20,750 股 PLTR 股份。 出售事項 於二零二五年十二月十七日及二零二六年三月六日，本公司經其全資附屬公司於市 場上出售總數合共 2,700 股 PLTR 股份，平均售價約為每股 PLTR 股份 163.66 美元， 出售所得款項總額 441,880 美元，等值約港幣 3,446,664 元（不包括交易成本）。出 售事項後， ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00079 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.2 | HKD | | 400,000,000 | 本月底法定/註冊股本總額： HKD 400,000,000 FF301 第 1 頁 共 10 頁 v 1.2.0 F ...

Core Viewpoint - ST Huawen (000793.SZ) has received a civil ruling from the Haikou Intermediate People's Court, which has accepted the reorganization application from its creditor, Sanya Kelly Investment Co., Ltd. This development indicates significant financial distress for the company and may lead to further regulatory actions [1]. Group 1 - The Haikou Intermediate People's Court has officially accepted the reorganization application from Sanya Kelly, a creditor of the company [1]. - As a result of the court's ruling, the company's stock will be subject to delisting risk warning starting March 2, 2026, with the stock name changing to "*ST Huawen" while the security code remains "000793" [1]. - The daily price fluctuation limit for the company's stock will continue to be set at 5% [1]. Group 2 - The company's stock will be suspended from trading for one day starting February 27, 2026, and will resume trading on March 2, 2026 [1].

Core Viewpoint - ST Huawen (000793.SZ) has received a civil ruling from the Haikou Intermediate People's Court, which has accepted the reorganization application filed by its creditor, Sanya Kelly Investment Co., Ltd [1] Group 1: Legal Proceedings - The Haikou Intermediate People's Court has officially accepted the reorganization application from Sanya Kelly Investment Co., Ltd against ST Huawen [1] - The court's decision is documented in the civil ruling number (2024) Qiong 01 Po Shen 70 [1] Group 2: Stock Market Impact - As a result of the court's ruling, ST Huawen's stock will be subject to delisting risk warning starting from March 2, 2026, with the stock name changing to "*ST Huawen" [1] - The stock code will remain "000793," and the daily price fluctuation limit will still be set at 5% [1] - Trading of the company's stock will be suspended for one day starting from February 27, 2026, and will resume on March 2, 2026 [1]

Group 1 - The company ST Huawen (000793.SZ) has stated that it is currently not conducting business based on seedance technology [1]

Core Viewpoint - ST Renfu (600079.SH) announced a stock issuance to its controlling shareholder,招商生科, with the total fundraising amount expected to be no less than RMB 3 billion and no more than RMB 3.5 billion, aimed at various innovative drug development projects and working capital supplementation [1] Group 1 - The issuance is classified as a related party transaction [1] - The funds raised will be allocated to several projects, including the Yichang Renfu project, headquarters research institute project, and the construction of a complex formulation manufacturing base [1] - The net proceeds after deducting relevant issuance costs will be used for innovation drug R&D and digital construction projects [1]

Group 1 - The core point of the article is that ST Renfu (600079.SH) announced a plan to issue A-shares to a specific group, which is its controlling shareholder,招商生科, through cash subscription [1] - The total amount of funds raised from this issuance is expected to be no less than RMB 300 million and no more than RMB 350 million, which will be used for various projects including innovative drug research and development [1] - The net proceeds after deducting related issuance costs are intended for projects such as the Yichang Renfu project, headquarters research institute project, and the construction of a dual-use health and complex formulation manufacturing base [1]